Replies to post #7763 on Seelos Therapeutics Inc (SEEL)

[value1008]

The good news about these clinical trials for Vitaros and FemProx is that the effects can be assessed so rapidly and the data can therefore be compiled much faster than in, say, an oncology trial, where the effects must be measured in many months or years. Alprodstadil has already been studied over a fairly long period in its suppository and injection form, so long-term use of Vitaros or FemProx should not be an issue. JMO.....

[markkind]

Beyce a few years ago I actually found links to theose studies and posted them on the YMB Teh reports actually had comments for the scientists who ran them

I have not tried to find them again